Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
M&A / Property

Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

QIPT · Price

Executive Summary

  • Shareholders approved the special resolution to consummate a cash‑for‑shares arrangement with affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC at US $3.65 per share.
  • The vote satisfied both the 66⅔% overall approval threshold (98.9% of shares voted) and the minority‑shareholder protection test under MI 61‑101 (98.7% after excluded votes).
  • The Company will seek a final order from the Supreme Court of British Columbia on March 5, 2026, with completion expected in the near term pending court, regulatory and exchange approvals.

Key Details

  • Arrangement Consideration: US $3.65 per share (cash) for all issued and outstanding common shares.
  • Shareholder Participation: 29,672,136 shares represented (~66.93% of outstanding shares).
  • Approval Thresholds Met:
  • Overall vote: 98.9% of shares voted in favor (exceeds 66⅔%).
  • MI 61‑101 minority approval: 98.7% of eligible votes after exclusions (exceeds simple majority).
  • Next Steps:
  • Final order from the Supreme Court of British Columbia scheduled for March 5, 2026.
  • Subject to stock exchange and regulatory approvals; expected near‑term completion.
  • Filings: Form 8‑K filed with the SEC; proxy statement and management information circular dated Jan 23, 2026 available on SEDAR+ and the Company’s website.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from QUIPT HOME MEDICAL CORP. J